ResMed Inc. vs Tripadvisor Inc Common Stock — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Tripadvisor Inc Common Stock trades at $13.82 (market cap $1.68B). The key difference: ResMed Inc. is far larger — about 17.1× Tripadvisor Inc Common Stock's market cap, and ResMed Inc. pays a 1.21% dividend while Tripadvisor Inc Common Stock pays none. Which is the better fit depends on your goals.
| RMD | TRIP | |
|---|---|---|
Market Cap | $28.81B | $1.68B |
Sector | Health | Consumer Cyclical |
52-Week High | $293.73 | $19.14 |
52-Week Low | $182.82 | $9.24 |
Enterprise Value | $27.99B | $1.80B |
Dividend Yield | 1.21% | — |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →